HomeOpen Access NewsOAG 028 - October 2020

OAG 028 - October 2020

How DNA technology helps control the premium quality of Thai Hom Mali Rice

Professor Dr Apichart Vanavichit, at the Rice Science Center, explains how DNA technology can create a high-quality Thai Jasmine Rice.

Social value in public sector procurement

Mark Gair, MD of CDS and Fergus Bailie, CEO of the Bailie Group provide their opinion about the role of social value in public sector procurement.

Single-cell genomics: Clinical strategies for COVID-19

Here, Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group argues that single-cell genomics empowers clinical strategies for COVID-19.

Social value: How can the construction sector deliver a more tangible impact?

Bev Hurley CBE, Chair of the Institute of Economic Development, ponders how construction spend can address the significant inequalities facing disadvantaged and left-behind communities.

Potential implications of microplastics in human health and biodiversity

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, discusses the potential implications of microplastics in human health and biodiversity.

Reducing the burden of diabetes management through flexible and discreet insulin delivery

Alex Evans, UK Country Manager for ViCentra B.V., discusses how insulin pump system Kaleido can provide solutions to reduce the practical and emotional burden of living with diabetes.

Why COVID-19 is a concern for people with diabetes

Prof. Andrew Boulton, MD, DSc (Hon), FACP, FICP, FRCP, President of the International Diabetes Federation, highlights why COVID-19 is a particular concern for people living with diabetes.

The SP System: A promising foundation for the development of human-like general AI

Dr J Gerard Wolff, Director at CognitionResearch.org describes the SP System – a promising foundation for the development of human-like general artificial intelligence.

Brexit impact: Health and brain research

Prof Monica Di Luca, President, European Brain Council, sheds light on the greater impact of Brexit in terms of health and brain research being up for negotiation.

Alzheimer’s disease: Incurable but preventable?

Jonathan Baker of, GBS Clinic, sheds light on the current extent of our knowledge of Alzheimer’s disease.

Eye health: Diabetic Retinal Screening

Max Halford FBDO CL, Clinical Lead for the Association of British Dispensing Opticians, tells us what we need to know about Diabetic Retinal Screening in this eye health focus.

Medical school curriculum must include health technology

Dr Ravi Tomar discusses why the medical school curriculum must include health technology.

Moving the climate discussion towards concrete action

Tomer Shalit, CEO and Founder of ClimateView, shares his reflections on moving the climate discussion beyond the diagnostic paradigm and towards concrete action.

The role of technology in ophthalmology

Mr Romesh Angunawela, Founding Partner, Ophthalmic Consultants of London, enlightens us on the role of technology in ophthalmology as part of the NHS’s efforts to tackle the COVID backlog.

Ensuring artificial intelligence is humane and regulated

Alejandro Saucedo, Member of the European Commission's High Level Expert Group Reserve List on AI and Engineering Director at Seldon, argues that to ensure artificial intelligence is humane, it must be regulated.

Government frameworks open the door to easier procurement of services for local authorities

In this interview, Jonny Combe, UK CEO at PayByPhone explains why government procurement frameworks provide a more accessible and convenient way to procure public services, saving local authorities money and time in the process.

Heart disease: The collateral damage of COVID-19

Professor Lina Badimon and Elisabetta Zanon from the European Society of Cardiology provide their thoughts on understanding and addressing the impact of COVID-19 on heart disease.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders